CMHC West CME Symposia

Register Now

CME Breakfast Symposium

Friday, August 7, 2020 · 6:00 – 7:15 AM

Challenging the Status-Quo: The Cardiorenal Protection with SGLT-2 Inhibitors in T2DM and Beyond--Expert Debate and Discussions

Chaired by: TBD


After completing this activity, the participant should be better able to:

Review the association and the pathophysiology between T2D and CKD, and the impact of concomitant CKD and T2D on patient outcomes

Employ the diagnostic criteria according to evidence-based guidelines for DKD in patients with T2DM at risk for kidney disease progression

Utilize current treatment options for patients with DKD based on identified benefits and risks, and current guideline recommendations

Review the efficacy and safety of emerging DKD treatments based on the latest evidence

Annenberg Center For Health Sciences
Postgraduate Institute For Medicine

This activity is jointly provided by Postgraduate Institute for Medicine and CMHC. Supported by an educational grant from AstraZeneca.

This activity is approved for AMA PRA Category 1 Credits™. This activity is eligible for ABIM MOC, ACPE, ANCC and CDR credit, see final activity announcement for specific details. For overall accreditation information on CMHC West 2020, please click here.

CME Breakfast Symposium

Saturday, August 8, 2020 · 6:00 – 7:15 AM